09262017Headline:

Reno, Nevada

HomeNevadaReno

Email Steven J. Klearman Steven J. Klearman on Twitter Steven J. Klearman on Facebook Steven J. Klearman on Avvo
Steven J. Klearman
Steven J. Klearman
Attorney • (800) 880-5297

Prescription tracking: Too invasive?

Comments Off

With prescription drug use at its highest in Nevada, and with overdoses from painkillers, including methadone, on the rise, prescription tracking programs are emerging all over the country.

Nevada was the first to implement such a program. The Nevada Pharmacy Board has developed a database listing every prescription written in Nevada for certain medications. The listing includes the provider and the patient, and is designed to prevent drug-seeking patients from obtaining prescriptions from multiple doctors.

To some, the potential privacy invasion from such programs is too invasive.

The Concord Monitor published an editorial on August 24 detailing concerns with the programs:

Some abused drugs are stolen, but most are obtained by filling prescriptions from doctors. Abusers go from doctor to doctor and, since a physician has no way of knowing whether another doctor has just written a prescription for the same drug, get multiple prescriptions. Drug monitoring programs, proponents say, greatly reduce doctor shopping. And they allow doctors, who, when they punch in a security code, see the patient’s prescription history, to see when potential harmful or fatal interactions could occur between drugs prescribed by different physicians.

Though more than 30 states have sanctioned the creation of a prescription monitoring system, most are too new to judge their effectiveness. The oldest programs were adopted by Nevada in 1997 and Kentucky in 1999. Studies cited by the National Conference of State Legislatures suggest that the monitoring programs dramatically reduce prescription forgery and doctor shopping, but they also push abusers to states lacking a program and to the internet.

Every New England state but New Hampshire has now approved a monitoring program, so attempts to procure drugs illegally here will likely increase. That means greater vigilance on the part of the local medical community and increased scrutiny by law enforcement will be necessary.

The push for monitoring is coming not just from doctors and public health officials but the attorney general’s office. And it would likely be a useful tool. But it’s easy to imagine a time when lobbyists could convince lawmakers that the drug problem has become severe enough to grant law enforcement agencies unfettered access to everyone’s prescription history without a warrant. Then, agents would view the private medical information of hordes of innocent people in hopes of nabbing a small number of abusers.

Even more troubling is the thought that computer hackers or bribed employees could obtain the records and sell them. The information would be very valuable to pharmaceutical companies, and to insurers and employers who want to avoid both abusers and people in need of expensive health care.

Banks, major retail chains, communications systems and federal agencies including the Department of Veterans Affairs, FEMA, the nation’s nuclear laboratories, companies working for the Department of Homeland Security, the CIA and the FBI have all been breached with some degree of success by hackers or had information stolen or lost.

Privacy concerns have trumped the potential value of establishing a prescription monitoring program three times in the past.

Not enough has changed to recommend that lawmakers change course.

You can see the full article here